Literature DB >> 22327498

The impact of European vaccination policies on seasonal influenza vaccination coverage rates in the elderly.

Patricia Blank1, Matthias Schwenkglenks, Thomas D Szucs.   

Abstract

Despite strong recommendations, seasonal influenza vaccination coverage rates (VCRs) remain limited in Europe, even in high-priority groups. There is a need for understanding the impact of vaccination-related policy elements and barriers toward vaccination. We aimed at assessing essential elements of vaccination policies and the influence of policy-related driving factors on VCRs among elderly. Sixteen European National Vaccine Industry Groups (NVIGs) were included in a survey to make an inventory of vaccination policies implemented at national level (2009). The questionnaire was structured around four topics: management of vaccination programs; influence of health care workers (HCWs); role of information/ communication campaigns; and access to vaccine. The information retrieved was put in relation to current VCRs among the elderly (≥ 65 y). Correlation coefficients between policy elements and vaccination rates were calculated. Several policy elements may be suitable to increase influenza vaccination uptake in the elderly, but only few countries make use of all alternatives. Countries with good monitoring systems regarding vaccine uptake rates (Spearman's rho = 0.639, p = 0.010) or sending personal letters offering free vaccination (Sp = 0.728, p = 0.002) showed on average higher coverage among the elderly than countries with less developed vaccine management systems. The presence of additional policy elements (setting national objectives, HCW incentives, vaccination reimbursement systems, awareness campaigns and clear VCR objectives) led to numerically increased VCRs. The presence of several elements of vaccination policies at national level, including broad information and reminding systems, strong official recommendations and good access to the vaccine may help to achieve improved influenza vaccine coverage rates among elderly.

Mesh:

Substances:

Year:  2012        PMID: 22327498     DOI: 10.4161/hv.18629

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  18 in total

1.  Costs associated with influenza-related hospitalization in the elderly.

Authors:  Núria Torner; Encarna Navas; Núria Soldevila; Diana Toledo; Gemma Navarro; Aurea Morillo; Maria José Pérez; Angela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

2.  Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.

Authors:  F Milanetti; V Germano; R Nisini; I Donatelli; A Di Martino; M Facchini; C Ferlito; A Cappella; D Crialesi; S Caporuscio; R Biselli; F Rossi; S Salemi; R D'Amelio
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  Willingness of European healthcare workers to undergo vaccination against seasonal influenza: current situation and suggestions for improvement.

Authors:  George Kassianos
Journal:  Drugs Context       Date:  2015-01-21

4.  The influence of partial public reimbursement on vaccination uptake in the older population: a cross-sectional study.

Authors:  Sheena M Mc Hugh; John Browne; Ciaran O'Neill; Patricia M Kearney
Journal:  BMC Public Health       Date:  2015-02-05       Impact factor: 3.295

5.  Beyond fragmentary: A proposed measure for travel vaccination concerns.

Authors:  Charles Atanga Adongo; Edem Kwesi Amenumey; Akwasi Kumi-Kyereme; Eve Dubé
Journal:  Tour Manag       Date:  2020-09-13

6.  Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.

Authors:  Micha Loebermann; Ulrich Voss; Seetha Meyer; Dietrich Bosse; Carlos Fritzsche; Sebastian Klammt; Silvius Frimmel; Diana Riebold; Emil C Reisinger
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

7.  Seasonal influenza vaccination coverage rate of target groups in selected cities and provinces in China by season (2009/10 to 2011/12).

Authors:  Lei Zhou; Qiru Su; Zhen Xu; Ao Feng; Hui Jin; Shiyuan Wang; Zijian Feng
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

8.  Annual public health and economic benefits of seasonal influenza vaccination: a European estimate.

Authors:  Emmanuelle Preaud; Laure Durand; Bérengère Macabeo; Norbert Farkas; Brigitte Sloesen; Abraham Palache; Francis Shupo; Sandrine I Samson
Journal:  BMC Public Health       Date:  2014-08-07       Impact factor: 3.295

9.  Medical and economic burden of influenza in the elderly population in central and eastern European countries.

Authors:  Gábor Kovács; Zoltán Kaló; Karina Jahnz-Rozyk; Jan Kyncl; Agnes Csohan; Adriana Pistol; Mariya Leleka; Rafail Kipshakbaev; Laure Durand; Bérengère Macabeo
Journal:  Hum Vaccin Immunother       Date:  2013-10-28       Impact factor: 3.452

10.  Influenza vaccination: key facts for general practitioners in Europe-a synthesis by European experts based on national guidelines and best practices in the United Kingdom and the Netherlands.

Authors:  George Kassianos; Patricia Blank; Oana Falup-Pecurariu; Ernest Kuchar; Jan Kyncl; Raul Ortiz De Lejarazu; Aneta Nitsch-Osuch; Gerrit A van Essen
Journal:  Drugs Context       Date:  2016-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.